Baillie Gifford acquired 6.61M Sana Biotechnology shares worth $19.6M. That's 0.02% of their equity portfolio (181st largest holding). The investor owns 2.13% of the outstanding Sana Biotechnology stock. The first Sana Biotechnology trade was made in Q1 2021. Since then Baillie Gifford bought shares five more times and sold shares on fourteen occasions. The investor's estimated purchase price is $181M, resulting in a loss of 89%.